Journal of Hospice and Palliative Care

  • 제22권2호
  • /
  • Pages.100-104
  • /
  • 2019
  • /
  • 2765-3072(pISSN)
  • /
  • 2765-3080(eISSN)
한국호스피스완화의료학회 (Korean Society for Hospice and Palliative Care)
권호 표지
DOI QR코드

DOI QR Code

아편유사제를 사용한 암환자에서 발생한 통각과민 2례

Two Cases of Opioid-Induced Hyperalgesia in Cancer Patients Treated with Opioids for Pain Management

  • Hong, Sukchul (Department of Internal Medicine, Kangdong Sacred Heart Hospital) ;
  • Kwon, Jung Hye (Department of Internal Medicine, Kangdong Sacred Heart Hospital) ;
  • Han, Su Jung (Palliative Care Clinic, Kangdong Sacred Heart Hospital)
  • 투고 : 2018.11.08
  • 심사 : 2019.05.15
  • 발행 : 2019.06.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

아편유사제는 중증의 암성통증 조절의 중요한 약제이며 천장효과가 없다. 그러나 의식저하, 인지기능 저하, 환각, 섬망, 호흡저하, 근간대경련, 발작, OIH 등의 합병증으로 인해 용량증량에 제한이 있다. 아편유사제 유발 OIH증은 아편유사제에 노출된 환자에서 역설적으로 통증이 증가하는 현상이다. 이 경우 아편유사제의 용량을 줄이거나, 중단하거나 다른 종류의 아편유사제로 변경하거나 NMDA 길항제를 추가하는 것이 조절에 도움이 된다. 아편 주사제에 노출된 이후 발생한 OIH를 조절한 증례를 보고하고자 한다.

Opioids are important drugs for the management of severe cancer pain without a ceiling effect. However, opioid administration leads to dose-limiting complications including drowsiness, hallucinations, delirium, respiratory depression, cognitive impairment, seizure, myoclonus, and hyperalgesia. Opioid-induced hyperalgesia (OIH) is a paradoxical phenomenon as opioid exposure increases pain sensitivity. Reducing or stopping opioids, opioid rotation, or co-administration of N-methyl-D-aspartate (NMDA) antagonists have been suggested for the management of OIH. In this study, we report two clinical cases of successful management of OIH in cancer pain patients that were treated with opioids.

키워드

참고문헌

  1. Portenoy RK. Cancer pain. Epidemiology and syndromes. Cancer 1989;63(11 Suppl):2298-307. https://doi.org/10.1002/1097-0142(19890601)63:11<2298::AID-CNCR2820631140>3.0.CO;2-A
  2. Green CR, Hart-Johnson T, Loeffler DR. Cancer-related chronic pain: examining quality of life in diverse cancer survivors. Cancer 2011;117:1994-2003. https://doi.org/10.1002/cncr.25761
  3. Chwistek M. Recent advances in understanding and managing cancer pain. F1000Res 2017;6:945. https://doi.org/10.12688/f1000research.10817.1
  4. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Physician 2008r;11(2 Suppl):S105-20.
  5. Cohen AF, Burggraaf J, van Gerven JM, Moerland M, Groeneveld GJ. The use of biomarkers in human pharmacology (Phase I) studies. Annu Rev Pharmacol Toxicol 2015;55:55-74. https://doi.org/10.1146/annurev-pharmtox-011613-135918
  6. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011;14:145-61.
  7. Shi S, Klotz U. Age-related changes in pharmacokinetics. Curr Drug Metab 2011;12:601-10. https://doi.org/10.2174/138920011796504527
  8. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep 2016;65:1-49. https://doi.org/10.15585/mmwr.rr6501e1
  9. Chau DL, Walker V, Pai L, Cho LM. Opiates and elderly: use and side effects. Clin Interv Aging 2008;3:273-8. https://doi.org/10.2147/CIA.S1847
  10. Thwaites D, McCann S, Broderick P. Hydromorphone neuroexcitation. J Palliat Med 2004;7:545-50. https://doi.org/10.1089/jpm.2004.7.545
  11. Lim KH, Nguyen NN, Qian Y, William JL, Lui DD, Bruera E, Yennurajalingam S. Frequency, Outcomes, and Associated Factors for Opioid-Induced Neurotoxicity in Patients with Advanced Cancer Receiving Opioids in Inpatient Palliative Care. J Palliat Med. In press 2018.
  12. Fallon M, Cherny N. Opioid therapy: optimizing analgesic outcomes. In: Cherny NI, Fallon M, Kassa S, Portenoy RK, Currow D, eds. Oxford textbook of palliative medicine. 5th ed. Oxford:Oxford University Press;2018. p.525-59.
  13. Bekhit MH. Opioid-induced hyperalgesia and tolerance. Am J Ther 2010;17:498-510. https://doi.org/10.1097/MJT.0b013e3181ed83a0
  14. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006;104:570-87. https://doi.org/10.1097/00000542-200603000-00025
  15. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Physician 2008;11(2 Suppl):S105-20.
  16. Mercadante S, Arcuri E. Hyperalgesia and opioid switching. Am J Hosp Palliat Care 2005;22:291-4. https://doi.org/10.1177/104990910502200411
  17. Celerier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P et al. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 2000;92:465-72. https://doi.org/10.1097/00000542-200002000-00029
  18. Mao J, Price DD, Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 1994;14:2301-12. https://doi.org/10.1523/JNEUROSCI.14-04-02301.1994
  19. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011;14:145-61.
  20. Roeckel LA, Le Coz GM, Gaveriaux-Ruff C, Simonin F. Opioid-induced hyperalgesia: Cellular and molecular mechanisms. Neuroscience 2016;338:160-82. https://doi.org/10.1016/j.neuroscience.2016.06.029
  21. Park JH, Lim DH, Kim YH, Ryu KH, Moon DE. Pain managements in pancreatic cancer patient with opioid-induced hyperalgesia : A case report. Anesth Pain Med 2012;7:110-3.
  22. Mercadante S, Villari P, Ferrera P. Burst ketamine to reverse opioid tolerance in cancer pain. J Pain Symptom Manage 2003;25:302-5. https://doi.org/10.1016/S0885-3924(03)00047-2
  23. Romero-Alejo E, Puig MM, Romero A. Antihyperalgesic effects of dexketoprofen and tramadol in a model of postoperative pain in mice - effects on glial cell activation. J Pharm Pharmacol 2016;68:1041-50. https://doi.org/10.1111/jphp.12584
  24. Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, et al. Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways. Anesthesiology 2010;112:696-710. https://doi.org/10.1097/ALN.0b013e3181cd7920
  25. Abreu M, Aguado D, Benito J, Garcia-Fernandez J, Gomez de Segura IA. Tramadol-induced hyperalgesia and its prevention by ketamine in rats: A randomised experimental study. Eur J Anaesthesiol 2015;32:735-41. https://doi.org/10.1097/EJA.0000000000000296